RCUS - Arcus Biosciences - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RCUS is currently covered by 12 analysts with an average price target of $34. This is a potential upside of $9.59 (39.29%) from yesterday's end of day stock price of $24.41.

Arcus Biosciences's activity chart (see below) currently has 166 price targets and 157 ratings on display. The stock rating distribution of RCUS is 77.78% BUY and 22.22% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 45.38% with an average time for these price targets to be met of 264.79 days.

Highest price target for RCUS is $49, Lowest price target is $16, average price target is $34.

Most recent stock forecast was given by ROBERT DRISCOLL from WEDBUSH on 30-Sep-2026. First documented stock forecast 09-Apr-2018.

Currently out of the existing stock ratings of RCUS, 21 are a BUY (77.78%), 6 are a HOLD (22.22%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 08-Oct-2018

$43

$18.59 (76.16%)

$43

11 days ago
(30-Sep-2026)

8/19 (42.11%)

$17.17 (66.47%)

650

Hold Since 06-Aug-2026

$26

$1.59 (6.51%)

$23

2 months 5 days ago
(06-Aug-2026)

6/6 (100%)

$-2.33 (-8.22%)

208

Buy Since 03-Jun-2025

$45

$20.59 (84.35%)

$32

2 months 21 days ago
(20-Jul-2026)

7/10 (70%)

$16.83 (59.74%)

244

Hold Since 11-May-2026

$22

$-9 (-29.03%)

$20

5 months ago
(11-May-2026)

4/10 (40%)

$-2.86 (-11.50%)

195

Buy Since 07-May-2026

$34

$9.59 (39.29%)

$28

5 months 4 days ago
(07-May-2026)

2/3 (66.67%)

$9.22 (37.21%)

160

Show more analysts

Please expand the browser size to see the chart

What is RCUS (Arcus Biosciences) average time for price targets to be met?

On average it took 265 days for the stock forecasts to be reached, with an average price target met ratio of 45.38%.

Which analyst most recently updated their price target on RCUS (Arcus Biosciences)?

Robert Driscoll

Which analyst has the most public recommendations on RCUS (Arcus Biosciences)?

Robert Driscoll works at WEDBUSH and has 13 price targets and 11 ratings on RCUS

Which analyst is the currently most bullish on RCUS (Arcus Biosciences)?

Kaveri Pohlman with the highest potential upside of $45.59

Which analyst is the currently most reserved on RCUS (Arcus Biosciences)?

Peter Lawson with the lowest potential downside of -$17
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?